Clinical Trials on Breast Cancer Lymphedema in Canada
Total 3884 results
-
NSABP Foundation IncNational Cancer Institute (NCI); Radiation Therapy Oncology GroupActive, not recruitingStage II Breast Cancer | Stage IB Breast CancerUnited States, Canada, Israel, Puerto Rico, Korea, Republic of, Japan, Ireland
-
University of MichiganUniversity of Manitoba; M.D. Anderson Cancer Center; Memorial Sloan Kettering... and other collaboratorsCompletedBreast CancerUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States, Canada
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced, Androgen Receptor Positive Triple Negative Breast CancerUnited States, Spain, Belgium, Canada, Ireland, United Kingdom, Italy
-
Asociación para el Progreso de la Oncología en...Roche Farma, S.ACompleted
-
University of ManitobaCancerCare ManitobaUnknown
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
American College of Radiology Imaging NetworkNational Cancer Institute (NCI)CompletedBreast CancerUnited States, Canada, Argentina
-
Centre de recherche du Centre hospitalier universitaire...CompletedBreast Cancer | Colorectal CancerCanada
-
Gilead SciencesRecruitingStage IV Breast Cancer | Locally Advanced or Unresectable Metastatic Breast CancerTaiwan, Korea, Republic of, Greece, Spain, United States, Israel, France, Japan, Belgium, Poland, China, Singapore, Australia, Hungary, Czechia, Italy, South Africa, Hong Kong, Chile, Brazil, Argentina, Austria, Canada, Germany, Portugal, United Kingdom
-
Celldex TherapeuticsCompletedMetastatic gpNMB Over-expressing Triple Negative Breast CancerUnited States, France, Spain, Italy, Canada, Germany, Australia, Belgium, United Kingdom
-
Novartis PharmaceuticalsCompletedAdvanced Breast CancerBelgium, Italy, Czechia, Hungary, Canada, Netherlands, Germany, Singapore, Australia, Denmark, Poland, Switzerland, Korea, Republic of, Spain, Thailand, Lebanon, Austria, Bulgaria, Russian Federation, Norway, Jordan, United States, ... and more
-
University College, LondonNational Institute for Health Research, United KingdomUnknownEarly Breast CancerFrance, Korea, Republic of, United Kingdom, Italy, United States, China, Malaysia, Saudi Arabia, South Africa, Spain, Switzerland, Thailand
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Canadian Cancer Trials GroupActive, not recruitingStage II Breast Cancer | Stage IIIA Breast CancerUnited States, Canada, Puerto Rico
-
University Health Network, TorontoRecruitingBreast Cancer | Breast Neoplasms | Colorectal Neoplasms | Colorectal Cancer | Ovarian Cancer | Ovarian NeoplasmCanada
-
Janssen Diagnostics, LLCCompletedMetastatic Breast CancerUnited States, Canada
-
Nova Scotia Health AuthorityDalhousie UniversityCompletedCervical Cancer | Breast Cancer | Gynecologic Cancer | Ovarian Cancer | Uterine CancerCanada
-
Hoffmann-La RocheCompletedEarly Breast CancerSpain, Korea, Republic of, Australia, Taiwan, Ukraine, Poland, Russian Federation, United States, Germany, Brazil, Hungary
-
Sunnybrook Health Sciences CentreGenomic Health®, Inc.CompletedHormone Receptor Positive Malignant Neoplasm of BreastCanada
-
Merrimack PharmaceuticalsTerminatedBreast Cancer | HER2 Positive Breast CancerSpain, United States, Italy, France, Canada, Belgium, Austria, Germany, Czech Republic
-
NCIC Clinical Trials GroupCompletedBreast CancerCanada, United States
-
Ottawa Hospital Research InstituteUniversity of Ottawa; Bruyere Research InstituteRecruitingPain, Postoperative | Lymphedema | Seroma | Pain, ChestCanada
-
Novartis PharmaceuticalsCompletedColorectal Cancer, Triple Negative Breast Cancer, NSCLC - AdenocarcinomaUnited States, France, Taiwan, Canada, Italy, Singapore, Belgium, Spain, Israel
-
University of TorontoCanadian Institutes of Health Research (CIHR)Completed
-
Hamilton Health Sciences CorporationRecruitingBreast Cancer | Seroma Complicating A Procedure | Hematoma PostoperativeCanada
-
PfizerCompletedMetastatic Breast CancerSpain, Belgium, Sweden, United Kingdom, Austria, Germany, Switzerland
-
Sunnybrook Health Sciences CentrePrincess Margaret Hospital, Canada; North York General HospitalActive, not recruiting
-
McMaster UniversityDavid Braley and Nancy Gordon Chair in Family MedicineUnknownBreast NeoplasmCanada
-
Juravinski Cancer CenterCanadian Breast Cancer Foundation; Juravinski Cancer Centre FoundationUnknownBreast NeoplasmCanada
-
Hoffmann-La RocheTerminatedBreast CancerUnited States, Brazil, Australia, Canada, Japan, Korea, Republic of, Spain, United Kingdom
-
AstraZenecaActive, not recruitingAdvanced ER-Positive HER2-Negative Breast CancerUnited States, Italy, Spain, Belgium, Poland, Canada, Germany, Korea, Republic of, Russian Federation, France, Israel, Hungary, Portugal, United Kingdom, Georgia, Ukraine
-
Eli Lilly and CompanyCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States, Canada
-
MedSIRActive, not recruitingBreast Cancer MetastaticSpain
-
AVEO Pharmaceuticals, Inc.Astellas Pharma IncTerminatedTriple Negative Breast CancerGermany, Taiwan, Spain, Ukraine, Australia, Korea, Republic of, Canada, United States, Italy, Bahamas
-
Spanish Breast Cancer Research GroupRoche Farma, S.ACompleted
-
Spanish Breast Cancer Research GroupAstraZenecaTerminated
-
Hoffmann-La RocheRecruitingMetastatic Breast CancerUnited States, Korea, Republic of, Spain, Canada, Brazil, China, Singapore, Turkey, India, Argentina, Australia, Belgium, Finland, Hong Kong, South Africa, Italy, United Kingdom, Poland, Taiwan, Colombia, France, Germany, Mexico
-
SanofiActive, not recruitingBreast Cancer MetastaticKorea, Republic of, Belgium, Taiwan, China, France, United States, Argentina, Australia, Brazil, Canada, Czechia, Greece, Israel, Italy, Japan, Latvia, Mexico, Poland, Puerto Rico, Russian Federation, Spain, Turkey, Ukraine
-
Ontario Clinical Oncology Group (OCOG)Novartis PharmaceuticalsCompletedBreast CancerUnited States, Canada
-
SOLTI Breast Cancer Research GroupRoche Pharma AGRecruiting
-
NCIC Clinical Trials GroupCompleted
-
Novartis PharmaceuticalsTerminatedBreast CancerFrance, Canada, United Kingdom, Germany, Italy, United States
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Spain, Israel, Canada, Belgium, United Kingdom, France, Tunisia
-
Puma Biotechnology, Inc.CompletedBreast Cancer | Advanced Breast CancerKorea, Republic of, Taiwan, Hong Kong, United States, Japan, Croatia, United Kingdom, Hungary, Australia, Canada, Serbia, Singapore, South Africa, Poland, Spain, Russian Federation, Romania, Austria, Belgium, Bulgaria, Czechia, Fr... and more
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingChemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerRecurrent Breast Carcinoma | HER2/Neu Positive | Progesterone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States, Canada, Puerto Rico, Ireland
-
PfizerCompletedNeoplasmUnited States, Spain, Canada, Italy, United Kingdom
-
Novartis PharmaceuticalsTranslational Research in OncologyActive, not recruitingEarly Breast CancerUnited States, Belgium, Canada, Italy, United Kingdom, Hungary, Taiwan, Australia, Germany, Spain, Austria, Russian Federation, Korea, Republic of, China, France, Brazil, Ireland, Argentina, Romania, Poland
-
AstraZenecaActive, not recruitingHormone Receptor Positive Breast CancerCanada, Spain, United States, Romania, Taiwan, Italy, Brazil, Peru, Russian Federation, China, Czechia, Ukraine, South Africa, Japan, Poland, Mexico, United Kingdom, Argentina, Slovakia, Turkey
-
Eisai Inc.CompletedMetastatic Breast CancerPoland, Ukraine, United States, Taiwan, Spain, Argentina, Bulgaria, Romania, South Africa, Australia, Canada, Singapore, Russian Federation, Brazil, Germany, Hungary, Italy, Israel, Greece, Mexico, Belgium, Czechia, France